id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id FDA-2014-N-0355-0001,FDA,FDA-2014-N-0355,"Advisory Committee: Bone, Reproductive and Urologic Drugs Advisory Committee",Rule,Final Rule,2014-04-11T04:00:00Z,2014,4,2014-04-11T04:00:00Z,,2014-04-11T15:36:46Z,2014-08151,0,0,09000064816af6b1